Dysregulation of IFN system can lead to poor response to pegylated interferon and ribavirin therapy in chronic hepatitis C.

Dysregulation of IFN system can lead to poor response to pegylated interferon and ribavirin therapy in chronic hepatitis C.
复制标题

DOI:
10.1371/journal.pone.0019799
复制
发表时间:
2011
期刊:
影响因子:
3.7
通讯作者:
Murakami Y
Murakami Y
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Onomoto K;Morimoto S;Kawaguchi T;Toyoda H;Tanaka M;Kuroda M;Uno K;Kumada T;Matsuda F;Shimotohno K;Fujita T;Murakami Y

文献摘要

参考文献

被引文献

相似文献

尽管价格昂贵,但用于治疗慢性丙型肝炎 (CH) 的聚乙二醇化干扰素 (Peg-IFN)-α 和利巴韦林的标准组合会导致中等清除率和大量副作用。这使得有必要预测患者的结果,以提高治疗的准确性。尽管基因改变的 IL28B 的抗病毒机制尚不清楚,但 IL28B 多态性被认为是 IFN 联合治疗结果的良好预测因子。利用微阵列,我们对 87 个 CH 肝活检标本中 237 个 IFN 相关基因的表达谱进行了定量,以阐明 IFN 通路与病毒消除之间的关系,并预测患者的临床结果。我们还分析了 87 名患者中的 72 名患者的 IL28B 多态性 (rs8099917)。五个 IFN 相关基因(IFI27、IFI 44、ISG15、MX1 和 OAS1)在无应答者 (NR) 中的表达水平显着高于正常肝脏 (NL) 和持续病毒学应答者 (SVR);这种高表达也常见于具有次要(TG 或 GG)IL28B 基因型的病例。 NR和NL之间31个IFN相关基因的表达模式也存在显着差异。我们通过对角线线性判别分析 (DLDA) 预测 NR 中的药物反应,准确度为 86.1%。治疗前干扰素系统失调与干扰素治疗反应不佳有关。根据患者对联合治疗的反应确定 IFN 相关基因表达模式,使我们能够高精度预测药物反应。该方法可用于使用更个体化的方法为患者建立新的抗病毒疗法和策略。
Despite being expensive, the standard combination of pegylated interferon (Peg-IFN)- α and ribavirin used to treat chronic hepatitis C (CH) results in a moderate clearance rate and a plethora of side effects. This makes it necessary to predict patient outcome so as to improve the accuracy of treatment. Although the antiviral mechanism of genetically altered IL28B is unknown, IL28B polymorphism is considered a good predictor of IFN combination treatment outcome. Using microarray, we quantified the expression profile of 237 IFN related genes in 87 CH liver biopsy specimens to clarify the relationship between IFN pathway and viral elimination, and to predict patients' clinical outcome. In 72 out of 87 patients we also analyzed IL28B polymorphism (rs8099917). Five IFN related-genes (IFI27, IFI 44, ISG15, MX1, and OAS1) had expression levels significantly higher in nonresponders (NR) than in normal liver (NL) and sustained virological responders (SVR); this high expression was also frequently seen in cases with the minor (TG or GG) IL28B genotype. The expression pattern of 31 IFN related-genes also differed significantly between NR and NL. We predicted drug response in NR with 86.1% accuracy by diagonal linear discriminant analysis (DLDA). IFN system dysregulation before treatment was associated with poor IFN therapy response. Determining IFN related-gene expression pattern based on patients' response to combination therapy, allowed us to predict drug response with high accuracy. This method can be applied to establishing novel antiviral therapies and strategies for patients using a more individual approach.
DOI: 10.1074/jbc.m201641200
发表时间: 2002-06-14
影响因子: 4.8
作者:
Accola, MA;Huang, B;McNiven, MA
通讯作者: McNiven, MA
DOI: 10.1073/pnas.0901329106
发表时间: 2009-06-02
影响因子: 11.1
作者:
Critchley-Thorne, Rebecca J.;Simons, Diana L.;Lee, Peter P.
通讯作者: Lee, Peter P.
DOI: 10.1136/gut.2008.168948
发表时间: 2009-07-01
期刊: GUT
影响因子: 24.5
作者:
Mengshol, J. A.;Golden-Mason, L.;Rosen, H. R.
通讯作者: Rosen, H. R.
DOI: 10.1371/journal.pbio.0020108
发表时间: 2004-04
期刊: PLoS biology
影响因子: 9.8
作者:
Bair E;Tibshirani R
通讯作者: Tibshirani R
DOI: 10.1159/000087268
发表时间: 2006-01-01
期刊: Intervirology
影响因子: 4.6
作者:
Ikeda, Kenji;Arase, Yasuji;Kumada, Hiromitsu
通讯作者: Kumada, Hiromitsu